Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Omics and Imaging Study on the Mechanisms of Brain-heart Injury in Patients With Intracranial Hemorrhage

NCT06906432 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT06906432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06906432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Omics and Imaging Study on the Mechanisms of Brain-heart Injury in Patients With Intracranial Hemorrhage
Lead sponsor
Beijing Tiantan Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2024
Completion date
December 1, 2036
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, atrial fibrillation, cerebrocardiac syndrome, delayed cerebral ischemia, heart failure, heart infarction, hydrocephalus, intracerebral hemorrhage, ischemic heart disease, mass spectrometry, subarachnoid hemorrhage, aneurysmal, vasospasm, cerebral